AAUM (Average Assets Under Management) of ₹207.44 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.9% | 79.9% | ▲ +1.0% |
| Healthcare Services | 20.3% | 19.3% | ▼ -1.0% |
| Healthcare Equipment & Supplies | 1.0% | 1.0% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.9% | 80.9% | ▲ +1.0% |
| Healthcare Services | 19.3% | 18.5% | ▼ -0.8% |
| Healthcare Equipment & Supplies | 1.0% | 0.8% | ▼ -0.2% |
Comparing Sep 2026 → Oct 2026
| # | Stock | Sector | Sep 2026 | Oct 2026 | Change |
|---|---|---|---|---|---|
| 1 | Laurus Labs Limited ₹34.01 Cr |
Pharmaceuticals & Biotechnology | 11.84% | 14.12% | +2.28% |
| 2 | Acutaas Chemicals Ltd ₹7.54 Cr |
Pharmaceuticals & Biotechnology | 2.61% | 3.13% | +0.52% |
| 3 | Piramal Pharma Limited ₹5.39 Cr |
Pharmaceuticals & Biotechnology | 1.97% | 2.24% | +0.27% |
| 4 | Gland Pharma Limited ₹8.96 Cr |
Pharmaceuticals & Biotechnology | 3.55% | 3.72% | +0.17% |
| 5 | Syngene International Limited ₹2.78 Cr |
Healthcare Services | 1.06% | 1.15% | +0.09% |
| 6 | Natco Pharma Limited ₹2.80 Cr |
Pharmaceuticals & Biotechnology | 1.14% | 1.16% | +0.02% |
| 7 | Sai Life Sciences Limited ₹7.82 Cr |
Pharmaceuticals & Biotechnology | 3.24% | 3.25% | +0.01% |
| 8 | Onesource Specialty Pharma Limited ₹4.47 Cr |
Pharmaceuticals & Biotechnology | 1.84% | 1.85% | +0.01% |
| # | Stock | Sector | Sep 2026 | Oct 2026 | Change |
|---|---|---|---|---|---|
| 1 | Wockhardt Limited ₹5.70 Cr |
Pharmaceuticals & Biotechnology | 2.68% | 2.37% | -0.31% |
| 2 | Neuland Laboratories Limited ₹6.17 Cr |
Pharmaceuticals & Biotechnology | 2.83% | 2.56% | -0.27% |
| 3 | Biocon Limited ₹8.90 Cr |
Pharmaceuticals & Biotechnology | 3.96% | 3.70% | -0.26% |
| 4 | Krishna Institute Of Medical Sciences Limited ₹6.80 Cr |
Healthcare Services | 3.06% | 2.82% | -0.24% |
| 5 | Lupin Limited ₹17.73 Cr |
Pharmaceuticals & Biotechnology | 7.57% | 7.36% | -0.21% |
| 6 | GlaxoSmithKline Pharmaceuticals Limited ₹3.75 Cr |
Pharmaceuticals & Biotechnology | 1.76% | 1.56% | -0.20% |
| 7 | Glenmark Pharmaceuticals Limited ₹12.56 Cr |
Pharmaceuticals & Biotechnology | 5.40% | 5.22% | -0.18% |
| 8 | Abbott India Limited ₹4.85 Cr |
Pharmaceuticals & Biotechnology | 2.17% | 2.01% | -0.16% |
| 9 | Global Health Limited ₹4.09 Cr |
Healthcare Services | 1.86% | 1.70% | -0.16% |
| 10 | Poly Medicure Limited ₹2.01 Cr |
Healthcare Equipment & Supplies | 0.98% | 0.83% | -0.15% |
30 stocks — Oct 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹34.01 Cr |
Pharmaceuticals & Biotechnology |
14.12%
|
|
| 2 |
₹17.73 Cr |
Pharmaceuticals & Biotechnology |
7.36%
|
|
| 3 |
₹16.87 Cr |
Pharmaceuticals & Biotechnology |
7.00%
|
|
| 4 |
₹14.53 Cr |
Healthcare Services |
6.03%
|
|
| 5 |
₹12.56 Cr |
Pharmaceuticals & Biotechnology |
5.22%
|
|
| 6 |
₹11.19 Cr |
Pharmaceuticals & Biotechnology |
4.65%
|
|
| 7 |
₹10.26 Cr |
Pharmaceuticals & Biotechnology |
4.26%
|
|
| 8 |
₹9.72 Cr |
Pharmaceuticals & Biotechnology |
4.04%
|
|
| 9 |
₹8.96 Cr |
Pharmaceuticals & Biotechnology |
3.72%
|
|
| 10 |
₹8.90 Cr |
Pharmaceuticals & Biotechnology |
3.70%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.